Chris Jewell
Net worth: - $ as of 30/04/2024
Profile
Chris Jewell is a Professor at the University of Maryland and the Chief Scientific Officer at Cartesian Therapeutics, Inc. He previously held the position of Chief Scientific Officer at Cartesian Therapeutics, Inc. in 2023.
He earned a doctorate degree from the University of Wisconsin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 18/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Chris Jewell active positions
| Companies | Position | Start |
|---|---|---|
| University of Maryland | Corporate Officer/Principal | - |
Former positions of Chris Jewell
| Companies | Position | End |
|---|---|---|
Cartesian Therapeutics, Inc.
 Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | 13/11/2023 |
Training of Chris Jewell
| University of Wisconsin | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Commercial Services |
- Stock Market
- Insiders
- Chris Jewell
